Omnia Family Wealth, LLC Gilead Sciences, Inc. Transaction History

Omnia Family Wealth, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 07, 2019	SELL	$61.87 - $69.38 $866 - $971	-14 Closed	0 $0
Q4 2018 Feb 26, 2019	SELL	$60.54 - $79.0 $3,450 - $4,503	-57 Reduced 80.28%	14 $1,000
Q2 2018 Aug 10, 2018	SELL	$64.88 - $75.68 $18,361 - $21,417	-283 Reduced 79.94%	71 $5,000
Q1 2018 May 11, 2018	SELL	$72.84 - $88.8 $9,979 - $12,165	-137 Reduced 27.9%	354 $27,000
Q4 2017 Feb 02, 2018	BUY	$71.15 - $83.52 $1,494 - $1,753	21 Added 4.47%	491 $35,000
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $24,733 - $29,316	343 Added 270.08%	470 $38,000
Q2 2017 Aug 10, 2017	BUY	N/A	127	127 $9,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Omnia Family Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Omnia Family Wealth, LLC with notifications on news.